← Back

Sino BiologicalInc.

Sino Biological, Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. Its offerings include recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification products, qPCR primers, cell lysates, and purification reagents. The company also offers solutions for areas such as autoimmune disease research, kinase drug discovery, cytokine and growth factor research, SARS-CoV-2 variant research, CAR-T therapy, 3D organoids, ADC development, influenza vaccine development, multispecific antibody development, MSC therapy, and in vitro efficacy evaluation. It serves academic research institutions, biotech companies, and pharmaceutical companies, and was founded in 2016 with headquarters in Beijing, China.

Price · split & dividend adjusted
News & notes moving 301047.CS
China
301047.CS▲

Xinhua Winshare leads media sector with 5 consecutive limit-ups, plans to acquire Sichuan Nationalities Publishing House for 346 million yuan

On September 24, major A-share indices opened lower, while the media sector bucked the trend in early trading. Xinhua Winshare hit its fifth consecutive limit-up, Xinhua Media its fourth, and Topway Video its third, with Guangdong Media and Inner Mongolia Xinhua Distribution also among the top gainers. In news, Xinhua Winshare recently announced plans to use its own funds to acquire the 100% equity stake in Sichuan Nationalities Publishing House held by its controlling shareholder, Sichuan Xinhua Publishing and Distribution Group, for 346 million yuan. The transaction constitutes a related-party transaction but does not constitute a major asset restructuring. On the same day, Bairui Gene debuted on the Beijing Stock Exchange, opening 347.23% higher and rising more than 400% as of press time, with an issue price of 16.77 yuan. The company focuses on the research, production, and sales of biomedical materials and other products. The AI-driven drug discovery concept saw a sudden surge, with Berry Genomics hitting the daily limit-up in a straight line, and BGI Genomics, Rongtai Health, Saili Medical, Sino Biological, and Kingmed Diagnostics following higher. This came after the Ministry of Industry and Information Technology and nine other departments jointly issued the 15th Five-Year Plan for the development of the pharmaceutical industry, which explicitly calls for accelerating the use of artificial intelligence and other new technologies to empower drug research and development. The coal sector fluctuated higher, with Yunnan Coal Energy hitting the daily limit-up, briefly opening, and then sealing the limit-up again. Zhengzhou Coal Mining Machinery, Liaoning Energy, Antai Group, and Shaanxi Heimao followed higher. On September 24, the benchmark price for thermal coal on SunSirs was 989.50 yuan per ton, up 13.02% from 875.50 yuan per ton at the beginning of the month. The robotics concept saw localized movement, with Xiangyang Automobile Bearing hitting the limit-up, and Ningbo Dongli, Wanxiang Qianchao, Nanfang Precision, Sanhua Intelligent Controls, and Tuopu Group following higher. Tesla CEO Elon Musk said in an interview on September 23 that he predicts there will be at least 1 billion humanoid robots within 10 years or less, perhaps 10 billion in the next 15 years, and possibly 100 billion in the next 20 years. The real estate sector fell sharply, with Huali Family hitting the limit-down, Huayuan Holdings touching the limit-down, and Greenland Holdings, Heungkong Holdings, China Vanke, and Risesun Development quickly following lower.
0811-OL.HK · Capital · Positive Xinhua Winshare announced plans to acquire 100% of Sichuan Nationalities Publishing House for 346 million yuan, a related-party acquisition.
601811.CG · Capital · Positive Same company as Xinhua Winshare; its announced 346 million yuan acquisition of Sichuan Nationalities Publishing House is the news driving the fifth consecutive limit-up.
Sichuan Minzu Publishing House Co Ltd · Capital · Positive Xinhua Winshare plans to acquire 100% of Sichuan Nationalities Publishing House for 346 million yuan from its controlling shareholder.
Sichuan Xinhua Publishing and Distribution Group · Capital · Positive As controlling shareholder, Sichuan Xinhua Publishing and Distribution Group is selling its 100% stake in Sichuan Nationalities Publishing House for 346 million yuan.
000710.CS · Regulation · Positive Berry Genomics hit the daily limit-up as the AI-driven drug discovery concept surged after the MIIT-led 15th Five-Year Plan for pharma explicitly backed AI in drug R&D.
300676.CS · Regulation · Positive BGI Genomics rose with the AI-driven drug discovery concept after the MIIT-led 15th Five-Year Plan called for accelerating AI use in drug R&D.
Read original ↗
证券时报·11dRead more →
ChinaUnited States
Biotech & Genomic Medicine▲impact 4

CRO Concept Surges as Novoprotein Touches 20% Daily Limit Up

The CRO concept surged again in early trading today, with Novoprotein hitting the 20% daily limit up shortly after the open, following a limit-up close in the previous session. Hepalink and Baihua Pharmaceutical also reached their daily limit up, while Medicilon, HitGen, and Sino Biological rose over 7%. In news, CRO leader WuXi AppTec disclosed on Sunday evening that the U.S. District Court for the District of Columbia ruled on its motion for a preliminary injunction, shielding the company from immediate adverse effects of the 1260H designation during the judicial challenge. WuXi AppTec also released its half-year report on August 3, showing attributable net profit of 11.08 billion yuan in the first half of 2026, up 29.43% year-on-year, and raised its full-year 2026 guidance, with continuing operations revenue growth now expected at 35% to 39%, up from the previous 18% to 22%. Meanwhile, the aquaculture sector rebounded sharply, with Yisheng Livestock hitting the daily limit up within eight minutes of trading, Xiaoming Agriculture rising over 6%, and Minhe Animal Husbandry, Shennong Group, and Xiantan rising over 5%. The Dalian Commodity Exchange's live hog main contract LH2611 has rebounded over 4% cumulatively over the past five trading days. A Cinda Futures research note pointed out that the national breeding sow herd stood at 37.8 million head at the end of June 2026, a cumulative reduction of 7.35% from the earlier peak, while sample enterprise piglet births have declined for three consecutive months, strengthening expectations of far-month capacity reduction.
About megatrends
Biotech & Genomic Medicine › CDMO / Contract Manufacturing ▲Demand
603259.CG · Regulation · Positive Court ruling shields WuXi AppTec from immediate effects of 1260H designation, and raised guidance.
301047.CS · Demand · Positive CRO sector rally driven by WuXi AppTec's positive court ruling and strong earnings, lifting sector sentiment.
Read original ↗
上海证券报·56dRead more →